Plecanatide, a revolutionary medication for chronic idiopathic constipation (CIC), is the latest addition to the roster of products offered by Hangzhou Go Top Peptide Biotech Co., Ltd. As a leading China-based manufacturer, supplier, and factory of pharmaceutical products, Go Top Peptide Biotech is proud to introduce Plecanatide, the latest cutting-edge solution for the management of CIC. Plecanatide, a small peptide mimetic of human uroguanylin, is an orally administered medication that selectively targets the guanylate cyclase-C (GC-C) receptor found in the intestinal lining. By activating GC-C, Plecanatide increases concentrations of cyclic guanosine monophosphate (cGMP), leading to enhanced intestinal fluid secretion and motility. This results in an effective relief of constipation in adults affected by CIC. Go Top Peptide Biotech ensures that their products meet the highest standards of quality, effectiveness, and safety. With the introduction of Plecanatide, Go Top Peptide Biotech reaffirms its commitment to providing innovative and reliable solutions to patients worldwide.